Eyeworld

Archives EyeWorld.org EyeWorldTV.com EyeWorld ASCRS S AT U R DAY, M AY 16 , 2 0 2 0 | AS C R S V I R T U A L A N N U A L M E E T I N G DAILY NEWS HIGHLIGHTS ASCRS FOUNDATION UPDATE P. 6 FILM FESTIVAL PREVIEW P. 12 OPS WINNING IMAGES P. 28 way to help our members with the recovery process," he said. The meeting will feature more than 30 CME credits and more than 400 hours of content, and special sessions will highlight COVID-19-related content. Dr. Kim started by congrat- ulating and thanking Edward Holland, MD, chair of the ASCRS Program Committee, Steve Speares, ASCRS execu- tive director, ASCRS staff and leadership, industry sponsors, and participating faculty for by Ellen Stodola Editorial Co-Director T hough the ASCRS An- nual Meeting looks a bit different this year in its new, virtual for- mat, Terry Kim, MD, incoming president of ASCRS, said that it's a major step forward to ad- dress the current crisis, and he emphasized all the efforts that ASCRS is making to guide its members through these chal- lenging times. The Virtual Annual Meet- ing is an enormous initiative in terms of time and resources that ASCRS decided to under- take to address the COVID-19 crisis, Dr. Kim said. "We took this important step because we thought it would be the best their collaboration to make the very first Virtual Annual Meeting a reality. "We've never done a virtual meeting before, and due to having to cancel our Annual Meeting in Bos- ton fairly late, we didn't have much time to put this together. But thanks to the hard work and long hours put in by our Program Committee and ASCRS staff, we were able to produce a high-quality virtual Shifting gears to reflect on his year as president of ASCRS, Dr. Mamalis took a moment to pause and preface. "This terri- ble crisis in the whole country and what the entire profession is going through makes it diffi- cult to sit down and talk about what accomplishments have been done over the past year," Dr. Mamalis said. That said, he mentioned the rebranding of ASCRS that launched a year ago, making it clear what ASCRS does for its members and for surgeons. It's slogan—For surgeons. For you.—Dr. Mamalis said shows the commitment the society has for surgeons. "This is truly by Liz Hillman Editorial Co-Director N ick Mamalis, MD, outgoing president of ASCRS, shared his thoughts on the ASCRS Virtual Annual Meeting and his presidency as a whole. First, he gave "huge kudos" to the ASCRS staff and the Program Committee who took the full ASCRS Annual Meeting and distilled it into a 2-day virtual meeting in an extremely short period of time. "I'm very grateful that we were able to put togeth- er this meeting virtually," Dr. Mamalis said. "I am incredibly impressed at the amount of work everyone has been doing putting this together." Features he is excited for include the two-part "Turning the Lights Back On" session, which he said will be extremely timely for attendees. "The sessions on getting the practice going again, what are the steps to doing this … I think these are going to give invaluable information for people who are going through the process of restarting their practices," he said, adding later that these sessions come at a time when many states are be- ginning to loosen restrictions. He also noted the discus- sion with Scott Gottlieb, MD, former head of the FDA, who Dr. Mamalis said will likely offer valuable insights into this process. "The virtual meeting will also have the usual tremendous education that goes on at the ASCRS Annual Meeting," Dr. Mamalis said, mentioning that it even has a virtual exhibit hall for attendees to interact with industry representatives. continued on page 4 continued on page 3 Thoughts from outgoing ASCRS President Nick Mamalis, MD Incoming ASCRS President Terry Kim, MD, speaks about current situation and what ASCRS is doing to address this F R I DAY, J U LY 2 3 , 2 0 2 1 | A S C R S A N N UA L M E E T I N G DAILY NEWS EyeWorld: What was it like com- ing on as ASCRS president at the beginning of the pandemic? Dr. Kim: As I was taking on my role as president, I never imag- ined I'd face the immediate challenges that our organization had to face, but I was prepared to take on that challenge. I was thankful to have a strong and supportive organization in terms of the ASCRS staff, executive director, Executive Committee, and Governing Board to help nav- igate through the difficulties. For anyone dealing with this crisis, it was a dynamic, ever-evolving situ- ation; it was never just one thing. There were adjustments that were constantly being made in terms of our clinical care protocols, edu- cational offerings, governmental relief initiatives, and communica- tion with members. continued on page 4 continued on page 3 FOR MORE INFORMATION, VISIT US AT BOOTH #5201 SO YOUR PATIENTS DON'T HAVE TO © 2021 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA is a registered trademark of Ocular Therapeutix, Inc. PP-US-DX-0323 OT_ASCRS_Daily_News_Banner_MECH_07Jul2021.indd 4 OT_ASCRS_Daily_News_Banner_MECH_07Jul2021.indd 4 7/14/21 11:28 AM 7/14/21 11:28 AM Visit Booth 5208 to Hear What's New at BVI BVI and all other trademarks (unless noted otherwise) are property of BVI. BVI ©2021 Outgoing ASCRS president reflects on unprecedented year A Q&A with ASCRS president Richard Hoffman, MD R ichard Hoffman, MD, the current ASCRS president, has been involved with ASCRS, EyeWorld, and the Journal of Cataract & Refractive Surgery for years. He shared his thoughts on his presidency and his vision for the society. T erry Kim, MD, served as ASCRS president during a year full of unprecedent- ed challenges brought on by the COVID-19 pan- demic. He reflected on his year as president, the challenges and how ASCRS addressed them, import- ant initiatives, and more. EyeWorld: How and when did you first become involved with ASCRS? Dr. Hoffman: I became involved with ASCRS in the mid-1990s, in part due to the work my part- ner, Howard Fine, MD, had been doing with ASCRS. Howard was teaching at meetings and in- volved in the Governing Board and Executive Committee and Daily News In 2019, ASCRS again conducted its Clinical Survey, which identifies education gaps by compiling data from respondents about their experiences across specialties. The survey in- cluded questions on cataract, refractive, cor- nea, glaucoma, and retina surgery. Information collected is used by ASCRS to guide educational initiatives and activities. The 2019 survey had 1,204 total ASCRS member respondents, with 54.9% practicing in the U.S. and 45.1% practicing elsewhere. Of the respondents, 73.3% were male and 26.7% were female. The survey respondents had a wide range of experience, from those cur- rently in residency or fellowship (11.2%) to those who have been in practice more than 30 years (17.3%). The largest percentage of respondents was those who have been in practice 21–30 years (25.3%), and 64.1% of respondents have been in practice for more than 10 years. Respondents also varied in where they perform surgery, with the largest percentage (32%) performing surgery in a surgeon-owned ASC. CLINICAL SURVEY 2019 HIGHLIGHTS OF THE 2019 ASCRS CLINICAL SURVEY HOW MANY YEARS HAVE YOU BEEN IN PRACTICE? WHERE IS YOUR PRIMARY SURGERY LOCATION? (Select all that apply.) WHERE PRACTICE IS LOCATED MALE VS. FEMALE RESPONDENTS SUPPLEMENT TO EYEWORLD JUNE 2022 Supported by CONNECTING THE DOTS: Advancements in cataract surgery OCULAR SURFACE DISEASE IN MY SURGICAL PRACTICE: BEST MANAGEMENT SOLUTIONS the Journal of Cataract & Refractive Surgery in 2019, and the modern update is being prepared. Dr. Starr walked through the steps of the algorithm. The preop surgical visit is the last opportunity to detect OSD that could impact surgical outcomes. The first step is to acquire the non-invasive refractive and biometric measurements, with the caveat that these tests might need to be repeated at a subsequent visit if VS-OSD is detected. For cataract surgery, these may include optical biometry, keratometry, to- mography/topography, etc., and for laser vision correction, aberrometry, tomography, etc. The second step of the algorithm is the OSD screening battery. We're trying to identify all subtypes of OSD, he add- ed, not just dry eye disease. "We decided we would come up with a new term—VS-OSD," he said. VS-OSD is any OSD that can lead to IOL errors or refractive surprises, decreasing patient satisfaction and reducing visual quantity, quality, and performance postoperatively; it can lead to a post-surgical infection like endophthalmitis and/or non-visually signif- icant OSD that may worsen after surgery and become visual- ly significant. In any DED/OSD assessment you must inquire about symptoms, Dr. Starr said, but we all agree that signs are more important than symptoms in this particular population A n EyeWorld Corporate Education event during the 2024 AAO Annual Meeting focused on ocular surface disease. Kicking off the session, mod- erator Marjan Farid, MD, introduced speakers Christopher Starr, MD, Brandon Ayres, MD, and Francis Mah, MD, noting that they were all involved in the development of the ASCRS Preoperative OSD Algorithm to help physicians determine a course of action for these cases. The program was sponsored by AbbVie, Bausch + Lomb, Dompé, Johnson & Johnson Vision, Théa, and Tarsus. ASCRS Preoperative OSD Algorithm Dr. Starr gave an overview of the ASCRS Preoperative OSD Algorithm, which was created by the ASCRS Cornea Clinical Committee. "In the last 15 to 20 years, there's been a tremendous explosion of new knowledge when it comes to ocular sur- face and dry eye diseases. It's exciting for all of us who love the ocular surface; this is a great time to be involved in this area, but it can be overwhelming for some," he said, adding that many people aren't aware of the current guidelines and consensus recommendations. "In 2019, the ASCRS Cornea Clinical Committee decided to take this on as a primary educational initiative." There is a lot of data showing that OSD is present in most cataract patients, but many patients are asymptomatic. Visually significant OSD (VS-OSD) can reduce the accuracy of preoperative refractive measurements and may reduce visual quality, quantity, and performance postoperatively. Anterior blepharitis and bacterial biofilms increase the risk of endophthalmitis, and we know that most ocular surgeries will worsen OSD, he added. Dr. Starr said that 83% of respondents to an ASCRS Clinical Survey asked for a practical, efficient preop diag- nostic and treatment algorithm for addressing OSD. The ASCRS Cornea Clinical Committee set a goal of creating an algorithm that was consensus- and evidence-based, that could be integrated into the preoperative surgery visit, that had reliance on technicians and objective testing to reduce surgeon chair time, and that would identify all visually sig- nificant subtypes of OSD, not just DED, prior to surgery. Dr. Starr was tasked with leading this project, and he said the evolution of the algorithm took multiple iterations and a few years to get it right. It was originally published in During the LLPP (look, lift, pull, push) exam, the patient looked down, and visually significant collarettes and Demodex blepharitis were diagnosed. Source: Christopher Starr, MD Supplements Growing your practice with new techniques and technologies FOR SURGEONS. FOR YOU. WWW.EYEWORLD.ORG JUNE 2022 VOLUME 27, NUMBER 2 2022 ASCRS ANNUAL MEETING RECAP P. 38 STAR R I N G The 2025 ASCRS Annual Meeting CONSIDERING ENHANCEMENT RATES HANDLING STEROID- INDUCED GLAUCOMA DIGITAL TOOLS FOR SURGICAL TRAINING FOR SURGEONS. FOR YOU. WWW.EYEWORLD.ORG SPRING 2025 VOLUME 30, NUMBER 2 ASCRS ASCRS News resources

• Cover